Viveve announces regulatory approval for Viveve System in U.A.E. and Lebanon
Viveve Medical announced that the company has received regulatory approvals for the Viveve System in the United Arab Emirates, U.A.E., and Lebanon. The Viveve System is now cleared for marketing in 47 countries throughout the world. "U.A.E. and Lebanon represent very important markets for Viveve and the regulatory approvals of the Viveve System in these countries are significant developments. In partnership with our distribution partner, Medica Group, we have begun the commercialization efforts for the Viveve System in the Middle East to make this clinically-proven treatment available to women in the region whose quality of life is impacted by vaginal laxity," said Patricia Scheller, chief executive officer of Viveve.